Last reviewed · How we verify
IMP Application KM-001 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
IMP Application KM-001 (IMP Application KM-001) — Kamari Pharma Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IMP Application KM-001 TARGET | IMP Application KM-001 | Kamari Pharma Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IMP Application KM-001 CI watch — RSS
- IMP Application KM-001 CI watch — Atom
- IMP Application KM-001 CI watch — JSON
- IMP Application KM-001 alone — RSS
Cite this brief
Drug Landscape (2026). IMP Application KM-001 — Competitive Intelligence Brief. https://druglandscape.com/ci/imp-application-km-001. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab